Growth-related changes of phosphorus metabolites in VX-2 carcinoma implanted into rabbit thigh muscle: in vivo 31P MR spectroscopy
 

DOI: 10.18805/ijar.v0i0f.3798    | Article Id: B-343 | Page : 121-128
Citation :- Growth-related changes of phosphorus metabolites in VX-2 carcinoma implanted into rabbit thigh muscle: in vivo 31P MR spectroscopy .Indian Journal Of Animal Research.2017.(51):121-128

Hyeong-Kil Kim, Tae-Hoon Kim,  Gwang-Won Kim,  Jong-Bong Kim and Gwang-Woo Jeong
 

gwjeong@jnu.ac.kr
Address :

Research Institute of Medical Imaging, Department of Radiology, Chonnam National University Medical School, Gwangju, Republic of Korea.

Submitted Date : 15-06-2015
Accepted Date : 21-06-2016

Abstract

The purpose of this study was to evaluate the usefulness of in vivo 31P magnetic resonance spectroscopy (MRS) for monitoring changes in growth-related phosphate metabolite concentration and intracellular pH value in rabbit thigh muscle implanted with VX-2 carcinoma. The time-course magnetic resonance imaging (MRI) and in vivo 31P MRS were examined weekly in the course of 10 weeks following the onset of a VX-2 carcinoma implantation. The spectra were quantitatively analyzed to obtain vital information on the time course variation of the phosphorus metabolites and intracellular pH value according to the tumor growth. Elevation in the concentrations of phosphormonoesters (PME), inorganic phosphate (Pi), and phosphodiesters (PDE) was observed over the time course of 3-4 weeks after the implantation of VX2 carcinoma, while the rest of the metabolites, PCr and ATP tended to be constant. The concentration changes of PME, Pi, and PDE were positively correlated with the volumes of tumor necrosis. The intracellular pH values decreased with the time course of tumor growth and the volumes of tumor necrosis. In vivo 31P MRS is capable of non-invasive monitoring of intracellular pH values as well as the concentration changes of phosphate metabolites during tumor growth.
 

Keywords

in vivo 31P magnetic resonance spectroscopy (MRS) neoplasm phosphorus metabolites VX-2 carcinoma .

References

  1. Adam, J.A. and Bellomo, N. (1997). A survey of models for tumour-immune system dynamics Boston: Birkhauser.
  2. Aisen, A.M. and Chenevert, T.L. (1989). MR spectroscopy: Clinical perspective. Radiology, 173: 593-599.
  3. Choi, B.I., Lee, D.H. and Han, M.C. (1993). Necrotic areas in VX2 carcinoma of rabbits: Correlation of magnetic resonance imaging and pathologic appearance. Invest Radiol, 28: 33-38.
  4. Choi, J.A., Kang, E.Y., Kim, H.K., Song, I.C., Kim, Y.I. and Kang, H.S. (2008). Evolution of VX2 carcinoma in rabbit tibia: Magnetic resonance imaging with pathologic correlation. Clinical imaging, 32: 128-135.
  5. Cousins, J.P. (1995). Clinical MR spectroscopy: Fundamentals, current applications, and future potential. AJR Am J Roentgenol, 164: 1337-1347.
  6. Daly, P.F., Lyon, R.C., Faustino, P.J. and Cohen, J.S. (1987). Phospholipid metabolism in cancer cells monitored by 31p NMR spectroscopy. J Biol Chem, 262: 14875-14878.
  7. Dean, B., Drayer, B., Bird, C., Flom, R., Hodak, J., Coons, S. and Carey, R. (1990). Gliomas: Classification with MR imaging. Radiology, 174: 411-415.
  8. Evelhoch, J.L. (2001). pH and therapy of human cancers. Novartis Foundation symposium, 240: 68-80.
  9. Gerweck, L.E. (1998). Tumor pH: Implications for treatment and novel drug design. Semin Radiat Oncol, 8: 176-182. 
  10. Gupta, R.K. and Yushok, W.D. (1980). Noninvasive 31P NMR probes of free mg2+, mgatp, and mgadp in intact ehrlich ascites tumor cells. Proc Natl Acad Sci USA, 77: 2487-2491.
  11. Kim, G.W., Oh, C.H., Kim, J.C., Yoon, W., Jeong, Y.Y., Kim, Y.H., Kim, J.K., Park, J.G., Kang, H.K. and Jeong, G.W. (2016). Noninvasive biomarkers for acute hepatotoxicity induced by 1,3-dichloro-2-propanol: hyperpolarized 13C dynamic MR spectroscopy. Magn Reson Imaging, 34: 159-165.
  12. Kim, T.H., Jeong, G.W., Kim, T.S. and Kim, Y.H. (2015). Myocardial Metabolic Abnormality in a Primary Left Atrial Rhabdomyosarcoma: Localized 1H MR Spectroscopy. Iran J Radiol, 12: e17757. 
  13. Lee, K.H., Liapi, E., Buijs M., Vossen, J., Hong, K., Georgiades, C. and Geschwind, J.F. (2009). Considerations for implantation site of VX2 carcinoma into rabbit liver. J Vasc Interv Radiol, 20: 113-117.
  14. Mills, P., Buonomo, C., Pillai, R.P., Samphilipo, M.A., Rajaan, S.S., Strandberg, J.D. and Anderson, J.H. (1988). In vivo and in vitro 31P-NMR preliminary studies of the VX-2 carcinoma in rabbits. Invest Radiol, 23: 584-591.
  15. Podo, F. (1999). Tumour phospholipid metabolism. NMR Biomed, 12 : 413-439.
  16. Sijens, P.E., Wijrdeman, H.K., Moerland, M.A., Bakker, C.J., Vermeulen, J.W. and Luyten, P.R. (1988). Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T. Radiology, 169: 615-620.
  17. Sironi, S., Belloni, C., Taccagni, G. and Delmaschio, A. (1991). Invasive cervical carcinoma: MR imaging after preoperative chemotherapy. Radiology, 180: 719-722.
  18. Young, D.M., Fioravanti, J.L., Prieur, D.J. and Ward, J.M. (1976). Hypercalcemic vx-2 carcinoma in rabbits: A clinicopathologic study. Lab Invest, 35: 30-46.

Global Footprints